Wil J. Samson

Kerberos Proximal Solutions, Inc. is a medical device company. It develops solutions to treat vascular disease. The company develops proximal embolic-protection technology to recover debris dislodged during angioplasty and stent placement Investors. Kerberos Proximal Solutions was founded in 2001 and is headquartered in Cupertino, CA

Stellartech Research Corp. engages in the design, development and contract manufacture of medical systems utilizing radiofrequency, ultrasound and other energy sources. Its services include research and development, electrical and electronics engineering, software engineering, patient contact device engineering, and industrial and graphic design. Its products include diagnostic systems, and a range of patient contact devices such as surgical probes, balloon electrode catheters, and other catheters for minimally invasive therapies. The company was founded by Roger A. Stern in 1988 and is headquartered in Milpitas, CA.

Swan Ventures (Swan Ventures) is a venture firm founded in 2000. The firm is headquartered in Palo Alto, California.

Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA.

National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC.

Cardea Medsystems (Tianjin) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers endometrial ablation devices for treatment of idiopathic abnormal uterine bleeding diseases. The company was founded on April 7, 2009 and is headquartered in Tianjin, China.

Mirabilis Medica, Inc. engages in the development of non-invasive ultrasound technology for treatment of uterine fibroids. The company was founded in by Michael P. H. Lau, Alexander Lebedev and Shahram Vaezy August 2004 and is headquartered in Bothell, WA.

Amaranth Medical, Inc. develops and manufactures a technology platform for fully bioresorbable scaffolds. It operates as a holding company that engages in the development and manufacture of technology platform for fully bioresorbable scaffolds. Its proprietary bioresorbable technology platform holds great potential for both vascular and nonvascular applications. The company was founded by Freddy Yin Chiang Boey and Subbu S. Venkatraman in 2005 and is headquartered in Mountain View, CA.

Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA.

Viveve, Inc. engages in the development of medical devices that promote personal health and wellness. It offers InControl products and Viveve system solutions. The company was founded by Jonathan B. Parmer in 2005 and is headquartered in Englewood, CO.

Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA.

Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.